SRPT: Sarepta Therapeutics Inc. (DE) Stocks News on November 17, 2024

SRPT

Insider Monkey

2 days ago

Sarepta Therapeutics, Inc. (SRPT): Among 12 High Growth Large Cap Stocks to Buy Now

SRPT

Simply Wall St.

4 days ago

Why Sarepta Therapeutics' (NASDAQ:SRPT) Earnings Are Weaker Than They Seem

SRPT

Argus Research

5 days ago

SRPT: Lowering target price to $91.00

Sarepta recent weakness brings buying opportunity, says JPMorgan

SRPT

TipRanks

5 days ago

Sarepta recent weakness brings buying opportunity, says JPMorgan

Sarepta price target lowered to $193 from $200 at Baird

SRPT

TipRanks

9 days ago

Sarepta price target lowered to $193 from $200 at Baird

SRPT

Zacks

10 days ago

SRPT Beats on Q3 Earnings & Sales, Discontinues PPMO-Based DMD Program

SRPT

MT Newswires

10 days ago

Cantor Fitzgerald Upgrades Sarepta Therapeutics to Overweight, $167 Price Target

Sarepta scraps a Duchenne drug as gene therapy sales rise

SRPT

BioPharma Dive

10 days ago

Sarepta scraps a Duchenne drug as gene therapy sales rise

SRPT

MT Newswires

11 days ago

Sarepta Therapeutics Q3 Adjusted Earnings, Revenue Rise

SRPT

Motley Fool

11 days ago

Sarepta Therapeutics (SRPT) Q3 2024 Earnings Call Transcript

SRPT

GuruFocus.com

11 days ago

Sarepta Therapeutics Inc (SRPT) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

SRPT

Zacks

11 days ago

Sarepta Therapeutics (SRPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

SRPT

Associated Press Finance

11 days ago

Sarepta Therapeutics: Q3 Earnings Snapshot

Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments

SRPT

Business Wire

11 days ago

Sarepta Therapeutics Announces Third Quarter 2024 Financial Results and Recent Corporate Developments

SRPT

Argus Research

12 days ago

SRPT: Lowering target price to $100.00

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRPT

Business Wire

17 days ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRPT

Insider Monkey

21 days ago

Sarepta Therapeutics, Inc. (SRPT): An Unstoppable Stock That Could Make You Richer

Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results

SRPT

Business Wire

25 days ago

Sarepta Therapeutics to Announce Third Quarter 2024 Financial Results

Exploring High Growth Tech Stocks In United States October 2024

SRPT

Simply Wall St.

a month ago

Exploring High Growth Tech Stocks In United States October 2024

SRPT

MT Newswires

a month ago

Jefferies Initiates Sarepta Therapeutics at Buy With $165 Price Target

Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up

SRPT

Investor's Business Daily

a month ago

Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up

2 High-Flying Growth Stocks With Massive Upside Potential

SRPT

Motley Fool

a month ago

2 High-Flying Growth Stocks With Massive Upside Potential

SRPT

Insider Monkey

a month ago

Is Sarepta Therapeutics, Inc. (SRPT) the Most Promising Biotech Stock According to Hedge Funds?

SRPT

Argus Research

a month ago

SRPT: Lowering target price to $96.00

SRPT

MT Newswires

a month ago

RBC Lifts Price Target on Sarepta Therapeutics to $182 From $181, Keeps Outperform Rating

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics

SRPT

Motley Fool

a month ago

Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics

SRPT

Business Wire

2 months ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRPT

Insider Monkey

2 months ago

Is Sarepta Therapeutics, Inc. (SRPT) One of the Best Revenue Growth Stocks to Buy According to Analysts?

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress

SRPT

Business Wire

2 months ago

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2024 World Muscle Society Congress

Exploring TeraWulf And Two Other High Growth Tech Stocks

SRPT

Simply Wall St.

2 months ago

Exploring TeraWulf And Two Other High Growth Tech Stocks

SRPT

Insider Monkey

2 months ago

Sarepta Therapeutics (SRPT): Soaring with Successful Therapies and Cash Flow Positivity

SRPT

Zacks

2 months ago

Implied Volatility Surging for Sarepta Therapeutics (SRPT) Stock Options

Sarepta Therapeutics Appoints Deirdre Connelly to its Board of Directors

SRPT

Business Wire

2 months ago

Sarepta Therapeutics Appoints Deirdre Connelly to its Board of Directors

SRPT

Insider Monkey

2 months ago

Sarepta Therapeutics, Inc. (SRPT): Among Hedge Funds’ Top Biotech Stock Picks

SRPT

Motley Fool

2 months ago

These 2 Biotech Stocks Are Set to Soar

SRPT

Insider Monkey

2 months ago

Sarepta Therapeutics, Inc. (SRPT): This Biotech Stock Should Be On Your Radar

SRPT

Zacks

2 months ago

Why Is Sarepta Therapeutics (SRPT) Down 1.9% Since Last Earnings Report?

Sarepta Therapeutics Announces Recipients of the 7th Annual Route 79, The Duchenne Scholarship Program, for the 2024-2025 Academic Year

SRPT

Business Wire

2 months ago

Sarepta Therapeutics Announces Recipients of the 7th Annual Route 79, The Duchenne Scholarship Program, for the 2024-2025 Academic Year

Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy

SRPT

Benzinga

2 months ago

Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy

SRPT

Business Wire

3 months ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DMD clinical studies evolve with emphasis on building designs around relevant endpoints

SRPT

Clinical Trials Arena

3 months ago

DMD clinical studies evolve with emphasis on building designs around relevant endpoints

Sarepta Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

SRPT

Business Wire

3 months ago

Sarepta Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

SRPT

Argus Research

3 months ago

SRPT: Raising target price to $113.00

High Growth Tech Stocks To Watch In August 2024

SRPT

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In August 2024

SRPT

Argus Research

3 months ago

SRPT: Raising target price to $112.00

Heard Writers Pick Their Favorite and Least-Favorite Stocks

SRPT

The Wall Street Journal

3 months ago

Heard Writers Pick Their Favorite and Least-Favorite Stocks

SRPT

MT Newswires

3 months ago

Sarepta Therapeutics Insider Bought Shares Worth $4,955,728, According to a Recent SEC Filing

Bull Signal Flashing for Sarepta Therapeutics Stock

SRPT

Schaeffer's Investment Research

3 months ago

Bull Signal Flashing for Sarepta Therapeutics Stock

A $3 Million Gene-Therapy Maker at a Bargain Price

SRPT

The Wall Street Journal

3 months ago

A $3 Million Gene-Therapy Maker at a Bargain Price

SRPT

Simply Wall St.

3 months ago

Shareholders In Sarepta Therapeutics (NASDAQ:SRPT) Should Look Beyond Earnings For The Full Story

2 Biotech Stocks to Buy Hand Over Fist in August

SRPT

Motley Fool

3 months ago

2 Biotech Stocks to Buy Hand Over Fist in August

SRPT

Simply Wall St.

3 months ago

Some Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Analysts Just Made A Major Cut To Next Year's Estimates

How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics

SRPT

Investor's Business Daily

3 months ago

How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics

SRPT

MT Newswires

3 months ago

UBS Raises Sarepta Therapeutics Price Target to $188 From $173, Maintains Buy Rating

SRPT

Zacks

3 months ago

Down -10.33% in 4 Weeks, Here's Why You Should You Buy the Dip in Sarepta Therapeutics (SRPT)

SRPT

Simply Wall St.

3 months ago

Can Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Improve Its Returns?

SRPT

Thomson Reuters StreetEvents

3 months ago

Q2 2024 Sarepta Therapeutics Inc Earnings Call

SRPT

MT Newswires

3 months ago

Evercore ISI Upgrades Sarepta Therapeutics to Outperform From In Line, Adjusts Price Target to $179 From $185

SRPT

Zacks

3 months ago

Sarepta (SRPT) Q2 Earnings Top Estimates, Sales Lag, View Weak

SRPT

Motley Fool

3 months ago

Sarepta Therapeutics (SRPT) Q2 2024 Earnings Call Transcript

SRPT

Zacks

3 months ago

Compared to Estimates, Sarepta Therapeutics (SRPT) Q2 Earnings: A Look at Key Metrics

SRPT

Investing.com

3 months ago

Sarepta Therapeutics falls on revenue miss, weak outlook

SRPT

MT Newswires

3 months ago

Sarepta Therapeutics Swings to Q2 Non-GAAP Earnings; Revenue Rises

SRPT

Associated Press Finance

3 months ago

Sarepta Therapeutics: Q2 Earnings Snapshot

Sarepta Therapeutics Announces Second Quarter 2024 Financial Results and Recent Corporate Developments

SRPT

Business Wire

3 months ago

Sarepta Therapeutics Announces Second Quarter 2024 Financial Results and Recent Corporate Developments

SRPT

Zacks

3 months ago

What Makes Sarepta Therapeutics (SRPT) a New Buy Stock

SRPT

Insider Monkey

4 months ago

Sarepta Therapeutics (NASDAQ:SRPT) A Bull Case Theory

SRPT

Business Wire

4 months ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SRPT

Zacks

4 months ago

Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics

SRPT

MT Newswires

4 months ago

Sarepta Therapeutics Poised for 'Significant Launch Inflection' Amid Positive Elevidys Feedback, RBC Says

5 Biotech Stocks to Bet On Bright Industry Prospects

SRPT

Zacks

4 months ago

5 Biotech Stocks to Bet On Bright Industry Prospects

Sarepta Therapeutics to Announce Second Quarter 2024 Financial Results

SRPT

Business Wire

4 months ago

Sarepta Therapeutics to Announce Second Quarter 2024 Financial Results

SRPT

MT Newswires

4 months ago

RBC Upgrades Sarepta Therapeutics to Outperform From Sector Perform, Keeps Price Target at $182

SRPT

Argus Research

4 months ago

SRPT: Rating decreased to a SELL

This market expert warns real estate woes may not be limited to commercial — 3 'idiosyncratic' stocks he likes

SRPT

Moneywise

4 months ago

This market expert warns real estate woes may not be limited to commercial — 3 'idiosyncratic' stocks he likes

SRPT

Zacks

4 months ago

Wall Street Analysts Believe Sarepta Therapeutics (SRPT) Could Rally 38.04%: Here's is How to Trade

Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives

SRPT

GlobeNewswire

4 months ago

Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives

SRPT

Argus Research

4 months ago

SRPT: Raising target price to $156.00

SRPT

Zacks

4 months ago

What Makes Sarepta Therapeutics (SRPT) a Strong Momentum Stock: Buy Now?

SRPT

Argus Research

4 months ago

SRPT: Rating increased to a HOLD

SRPT

Zacks

4 months ago

Here's Why Sarepta (SRPT) Stock Price Surged 57% YTD

After a Big Win, Is Sarepta Therapeutics Stock a Buy?

SRPT

Motley Fool

4 months ago

After a Big Win, Is Sarepta Therapeutics Stock a Buy?

Has Sarepta Therapeutics Become a No-Brainer Stock Buy After This Recent FDA News?

SRPT

Motley Fool

4 months ago

Has Sarepta Therapeutics Become a No-Brainer Stock Buy After This Recent FDA News?

1 Soaring Growth Stock to Buy and Hold for 10 Years

SRPT

Motley Fool

4 months ago

1 Soaring Growth Stock to Buy and Hold for 10 Years

Best Momentum Stocks to Buy for July 3rd

SRPT

Zacks

4 months ago

Best Momentum Stocks to Buy for July 3rd

SRPT

Argus Research

4 months ago

SRPT: Rating decreased to a SELL

SRPT

Business Wire

5 months ago

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates

SRPT

Zacks

5 months ago

Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates

Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It.

SRPT

Motley Fool

5 months ago

Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It.

SRPT

MT Newswires

5 months ago

Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172

SRPT

MT Newswires

5 months ago

Citigroup Upgrades Sarepta Therapeutics to Neutral From Buy, Adjusts PT to $176 From $172

SRPT

GuruFocus.com

5 months ago

Insider Sale: EVP, General Counsel Ryan Brown Sells 38,957 Shares of Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Scores 90-Plus RS Rating On Muscular Dystrophy Approval

SRPT

Investor's Business Daily

5 months ago

Sarepta Therapeutics Scores 90-Plus RS Rating On Muscular Dystrophy Approval

SRPT

MT Newswires

5 months ago

Morgan Stanley Adjusts Sarepta Therapeutics' Price Target to $200 From $165, Keeps Overweight Rating

SRPT

MT Newswires

5 months ago

Evercore ISI Raises Price Target on Sarepta Therapeutics to $185 From $139, Maintains In Line Rating

SRPT

MT Newswires

5 months ago

BMO Capital Raises Price Target on Sarepta Therapeutics to $200 From $170, Maintains Outperform Rating

SRPT

Zacks

5 months ago

Company News for Jun 24, 2024

SRPT

Zacks

5 months ago

Sarepta Therapeutics (SRPT) Soars 30.1%: Is Further Upside Left in the Stock?

What next for gas prices, how the S&P 500 can reach 6,000: Market Domination

SRPT

Yahoo Finance Video

5 months ago

What next for gas prices, how the S&P 500 can reach 6,000: Market Domination

Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval In Muscular Dystrophy

SRPT

Investor's Business Daily

5 months ago

Latest Sarepta Therapeutics Inc. (DE) (SRPT) News on November 17, 2024

Share on Social Networks: